MART-1 Antigen With or Without TLR4 Agonist GLA-SE in Treating Patients With Stage II-IV Melanoma That Has Been Removed by Surgery

Clinical trial NCT02320305 · COMPLETED

Trial details

NCT number: NCT02320305
Sponsor: Mayo Clinic
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Stage IIA Skin Melanoma Stage IIB Skin Melanoma Stage IIC Skin Melanoma Stage IIIA Skin Melanoma Stage IIIB Skin Melanoma Stage IIIC Skin Melanoma Stage IV Skin Melanoma

Start date: 2015-01-27
Primary completion: 2015-12-07
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.